Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas D Klemen

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
JAMA Oncology|May 30, 2024
Results of the TARGET-TP Randomized Clinical TrialAaron J Dinerman, Nicholas D Klemen
Annals of Surgical Oncology|August 4, 2022
ASO Author Reflections: How Immunotherapy Could Change the Management of Responsive Solid TumorsNicholas D Klemen, Michael I D'Angelica
The New England Journal of Medicine|September 7, 2022
Prevention of Anal CancerPaolo Goffredo, Nicholas D Klemen, Imran Hassan
Surgical Oncology Clinics of North America|March 28, 2026
T-Cell Receptor Engineered T-Cell Therapy: A Rapidly Evolving Treatment Paradigm for Solid TumorsStav Leibou, Aaron J Dinerman, Nicholas D Klemen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2021
How Strong Is the Evidence Supporting Thromboprophylaxis in Surgical Oncology?Nicholas D Klemen, Paul L Feingold, Barry Hashimoto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2022
Reply to R.A. Snyder et alNicholas D Klemen, Paul L Feingold, Barry Hashimoto
Journal of Surgical Oncology|December 1, 2020
The emerging role of immunotherapy for the treatment of sarcomaNicholas D Klemen, Ciara M Kelly, Edmund K Bartlett
Surgical Oncology Clinics of North America|May 14, 2019
Role of Surgery in Combination with ImmunotherapyNicholas D Klemen, Mackenzie L Shindorf, Richard M Sherry
Annals of Surgical Oncology|December 14, 2017
Correction to: Metastasectomy for Tumor-Infiltrating Lymphocytes: An Emerging Operative Indication in Surgical OncologyJoseph G Crompton, Nicholas D Klemen, Udai S Kammula
The Lancet. Haematology|October 22, 2020
Mortality benefits of thromboprophylaxis - Authors' replyNicholas D Klemen, Paul L Feingold, Barry Hashimoto, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
JAMA Oncology|May 30, 2024
Results of the TARGET-TP Randomized Clinical TrialAaron J Dinerman, Nicholas D Klemen
Annals of Surgical Oncology|August 4, 2022
ASO Author Reflections: How Immunotherapy Could Change the Management of Responsive Solid TumorsNicholas D Klemen, Michael I D'Angelica
The New England Journal of Medicine|September 7, 2022
Prevention of Anal CancerPaolo Goffredo, Nicholas D Klemen, Imran Hassan
Surgical Oncology Clinics of North America|March 28, 2026
T-Cell Receptor Engineered T-Cell Therapy: A Rapidly Evolving Treatment Paradigm for Solid TumorsStav Leibou, Aaron J Dinerman, Nicholas D Klemen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2021
How Strong Is the Evidence Supporting Thromboprophylaxis in Surgical Oncology?Nicholas D Klemen, Paul L Feingold, Barry Hashimoto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2022
Reply to R.A. Snyder et alNicholas D Klemen, Paul L Feingold, Barry Hashimoto
Journal of Surgical Oncology|December 1, 2020
The emerging role of immunotherapy for the treatment of sarcomaNicholas D Klemen, Ciara M Kelly, Edmund K Bartlett
Surgical Oncology Clinics of North America|May 14, 2019
Role of Surgery in Combination with ImmunotherapyNicholas D Klemen, Mackenzie L Shindorf, Richard M Sherry
Annals of Surgical Oncology|December 14, 2017
Correction to: Metastasectomy for Tumor-Infiltrating Lymphocytes: An Emerging Operative Indication in Surgical OncologyJoseph G Crompton, Nicholas D Klemen, Udai S Kammula
The Lancet. Haematology|October 22, 2020
Mortality benefits of thromboprophylaxis - Authors' replyNicholas D Klemen, Paul L Feingold, Barry Hashimoto, et al.
Pageof 4